Partnering and collaboration for pharma, biotechs, healthcare and investors
Case study for novel adjuvants as technology platforms – ISCOMATRIX® adjuvant
Understanding the science and approach to safety
Advanced approach to CMC. Co-ordinated strategy
Debbie Drane
Debbie Drane has been with CSL in the R&D Division for over 25 years. During this time she has had a number of roles and has substantial experience in most areas of vaccine development. In particular ...